Evidence map›Paper›PMID 22674269›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2012

Acetylcholine receptor gating in a zebrafish model for slow-channel syndrome.

Michael Walogorsky, Rebecca Mongeon, Hua Wen, Gail Mandel, Paul Brehm

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. A mechano- and heat-gated two-pore domain KProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  3. Article
  4. Review
  5. Fatigue in Rapsyn-Deficient Zebrafish Reflects Defective Transmitter Release.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  6. Zebrafish mutants of the neuromuscular junction: swimming in the gene pool.The journal of physiological sciences : JPS · 2015
    Review
  7. A single mutation in the acetylcholine receptor δ-subunit causes distinct effects in two types of neuromuscular synapses.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  8. Review
  9. Zebrafish model for congenital myasthenic syndrome reveals mechanisms causal to developmental recovery.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Michael WalogorskyOregon Health & Science University, Portland, Oregon 97239, USA.
Rebecca Mongeon
Hua Wen
Gail Mandel
Paul Brehm
Oregon Health & Science University · USVollum Institute · US

Funding

Regulation of Acetylcholine Receptors on MuscleR37NS018205 · NINDS · STATE UNIVERSITY NEW YORK STONY BROOK · PI BREHM, PAUL · 2005 to 2011
$2.4M
REGULATION OF ACETYLCHOLINE RECEPTORS ON MUSCLER01NS018205 · NINDS · TUFTS UNIVERSITY BOSTON · PI BREHM, PAUL · 1985 to 2004
$1.8M
Howard Hughes Medical InstituteNINDS NIH HHS NS18205NINDS NIH HHS R01 NS018205NINDS NIH HHS R37 NS018205
6 · The paper itself

Abstract

Slow-channel syndrome (SCS) is an autosomal-dominant disease resulting from mutations in muscle acetylcholine (ACh) receptor subunits. The associated fatigue and muscle degeneration are proposed to result from prolonged synaptic responses that overload intracellular calcium. Single-channel studies on reconstituted receptors bearing human mutations indicate that the prolonged responses result from an increase in receptor open duration and, in some cases, increased sensitivity to ACh. We show that both of these aberrant receptor properties are recapitulated in heterozygotic zebrafish bearing an L258P mutation in the α subunit, thus affording the unique opportunity to compare the single-channel properties of mutant receptors to the synaptic currents in vivo. Whole-cell recordings revealed synaptic currents that decayed along a multiexponential time course, reflecting receptors containing mixtures of wild-type and mutant α subunits. Treatment with quinidine, an open-channel blocker used to treat the human disorder, restored fast synaptic current kinetics and the ability to swim. Quinidine block also revealed that mutant receptors generate a large steady-state current in the absence of ACh. The spontaneous openings reflected a destabilization of the closed state, leading to an apparent increase in the sensitivity of these receptors to ACh. The effective block by quinidine on synaptic currents as well as nonliganded openings points to dual sources for the calcium-dependent myopathy in certain forms of SCS.

Indexed as

Action PotentialsAnimalsCalciumChannelopathiesCholinergic AgonistsCholinergic AntagonistsDose-Response Relationship, DrugIon Channel GatingIsomerismMovementMuscle, SkeletalMyasthenic Syndromes, CongenitalOocytesPatch-Clamp TechniquesQuinidineReceptors, CholinergicCalciumCholinergic AgonistsCholinergic AntagonistsQuinidineReceptors, Cholinergic

Identifiers

PMID22674269
PMCPMC3390176
OpenAlexW2066438940

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.